FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
Parabilis Medicines, Inc.
Turning Point Therapeutics, Inc.
Actuate Therapeutics Inc.
Erasca, Inc.
PharmaMar
ViroMissile, Inc.
USWM, LLC (dba US WorldMeds)
SEED Therapeutics, Inc.
Angiex, Inc.
GlaxoSmithKline
Ocellaris Pharma, Inc.
Eli Lilly and Company
Var2 Pharmaceuticals
Degron Therapeutics Co.
Shasqi, Inc.
Bayer
AVM Biotechnology Inc
BioAtla, Inc.
Moonshot Antibodies
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Kazia Therapeutics Limited
Sensei Biotherapeutics, Inc.
Salutare Group Ltd.
PharmaMar
Tempus AI
Lantern Pharma Inc.
Intensity Therapeutics, Inc.
BeiGene
Pfizer
Immunophotonics, Inc.
Cyteir Therapeutics, Inc.
Taproot Health
Blueprint Medicines Corporation
Adaptimmune
Adaptimmune
Adaptimmune
EpicentRx, Inc.
Ipsen
Sumitomo Pharma America, Inc.
Novartis
Hutchmed
ImmunityBio, Inc.
Theseus Pharmaceuticals
Bayer
Catalysis SL
Celon Pharma SA
Sumitomo Pharma America, Inc.
OncoResponse, Inc.
RefleXion Medical
NBE-Therapeutics AG